SPRYCEL vs TASIGNA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Possible drug interaction. SPRYCEL and TASIGNA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	SPRYCEL	TASIGNA
Rating	72/100	70/100
Pharmacy pays	~$839.19 /30	—
Type	RX	RX
Active ingredient	DASATINIB	NILOTINIB HYDROCHLORIDE
Manufacturer	Bristol Myers Squibb	Novartis
Dosage forms	Tablet	Capsule
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	Boxed warning
Treats	Lymphoid Leukemia, Myeloid Leukemia	Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia

sprycel tasigna

Rating

72/100

70/100

Pharmacy pays

~$839.19 /30

—

Type

Active ingredient

DASATINIB

NILOTINIB HYDROCHLORIDE

Manufacturer

Bristol Myers Squibb

Novartis

Dosage forms

Tablet

Capsule

Drug class

Kinase Inhibitor

Boxed warning

None

Boxed warning

Treats

Lymphoid Leukemia, Myeloid Leukemia

Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia

Frequently asked questions

Which is better-rated, Sprycel or Tasigna?

By our independent rating, Sprycel scores higher — 3.6 vs 3.5 out of 5 for Tasigna. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Sprycel and Tasigna?

Sprycel contains Dasatinib, while Tasigna contains Nilotinib Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.